Showing results (21-30 of 33) with videos related to

Sort By:
Pageof 4
The Biochemical Journal|October 15, 2009
Fas/CD95 down-regulation in lymphoma cells through acquired alkyllysophospholipid resistance: partial role of associated sphingomyelin deficiencyWim J van Blitterswijk, Jeffrey B Klarenbeek, Arnold H van der Luit, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 15, 2006
Radiosensitization of squamous cell carcinoma by the alkylphospholipid perifosine in cell culture and xenograftsStefan R Vink, Saskia Lagerwerf, Elly Mesman, et al.
Molecular Cancer Therapeutics|August 19, 2007
A new class of anticancer alkylphospholipids uses lipid rafts as membrane gateways to induce apoptosis in lymphoma cellsArnold H van der Luit, Stefan R Vink, Jeffrey B Klarenbeek, et al.
The Journal of Pharmacology and Experimental Therapeutics|July 26, 2005
Coformulated N-octanoyl-glucosylceramide improves cellular delivery and cytotoxicity of liposomal doxorubicinRobert Jan Veldman, Gerben A Koning, Albert van Hell, et al.
Radiation Oncology (London, England)|October 27, 2009
AT-101, a small molecule inhibitor of anti-apoptotic Bcl-2 family members, activates the SAPK/JNK pathway and enhances radiation-induced apoptosisShuraila F Zerp, Rianne Stoter, Gitta Kuipers, et al.
The Journal of Biological Chemistry|April 14, 2004
Accumulation of glycosphingolipids in Niemann-Pick C disease disrupts endosomal transportDanielle te Vruchte, Emyr Lloyd-Evans, Robert Jan Veldman, et al.
The Biochemical Journal|July 29, 2011
Phosphoinositide phosphatase SHIP-1 regulates apoptosis induced by edelfosine, Fas ligation and DNA damage in mouse lymphoma cellsMaaike C Alderliesten, Jeffrey B Klarenbeek, Arnold H van der Luit, et al.
Molecular Biology of the Cell|September 28, 2007
Diacylglycerol kinase-alpha mediates hepatocyte growth factor-induced epithelial cell scatter by regulating Rac activation and membrane rufflingFederica Chianale, Santina Cutrupi, Elena Rainero, et al.
Scientific Reports|June 7, 2013
Defined lipid analogues induce transient channels to facilitate drug-membrane traversal and circumvent cancer therapy resistanceAlbert J van Hell, Manuel N Melo, Wim J van Blitterswijk, et al.
Pageof 4